nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazamide—ABCC8—ATP sensitive Potassium channels—ABCC9—dilated cardiomyopathy	0.141	0.27	CbGpPWpGaD
Tolazamide—KCNJ11—ATP sensitive Potassium channels—ABCC9—dilated cardiomyopathy	0.137	0.262	CbGpPWpGaD
Tolazamide—KCNJ1—Inwardly rectifying K+ channels—ABCC9—dilated cardiomyopathy	0.0537	0.103	CbGpPWpGaD
Tolazamide—ABCC8—Inwardly rectifying K+ channels—ABCC9—dilated cardiomyopathy	0.0274	0.0526	CbGpPWpGaD
Tolazamide—KCNJ11—Inwardly rectifying K+ channels—ABCC9—dilated cardiomyopathy	0.0266	0.051	CbGpPWpGaD
Tolazamide—Glyburide—ABCC9—dilated cardiomyopathy	0.0261	1	CrCbGaD
Tolazamide—Eruption—Furosemide—dilated cardiomyopathy	0.0247	0.0546	CcSEcCtD
Tolazamide—ABCC8—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.0243	0.0466	CbGpPWpGaD
Tolazamide—KCNJ1—Potassium Channels—ABCC9—dilated cardiomyopathy	0.0212	0.0406	CbGpPWpGaD
Tolazamide—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.0196	0.0433	CcSEcCtD
Tolazamide—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.0173	0.0382	CcSEcCtD
Tolazamide—Heartburn—Lisinopril—dilated cardiomyopathy	0.0165	0.0366	CcSEcCtD
Tolazamide—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0146	0.0322	CcSEcCtD
Tolazamide—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.0142	0.0315	CcSEcCtD
Tolazamide—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.0129	0.0287	CcSEcCtD
Tolazamide—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.0122	0.027	CcSEcCtD
Tolazamide—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.0113	0.025	CcSEcCtD
Tolazamide—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.0111	0.0245	CcSEcCtD
Tolazamide—Malaise—Spironolactone—dilated cardiomyopathy	0.011	0.0243	CcSEcCtD
Tolazamide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.0109	0.0241	CcSEcCtD
Tolazamide—ABCC8—Potassium Channels—ABCC9—dilated cardiomyopathy	0.0108	0.0208	CbGpPWpGaD
Tolazamide—KCNJ11—Potassium Channels—ABCC9—dilated cardiomyopathy	0.0105	0.0201	CbGpPWpGaD
Tolazamide—Discomfort—Spironolactone—dilated cardiomyopathy	0.0102	0.0227	CcSEcCtD
Tolazamide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00974	0.0216	CcSEcCtD
Tolazamide—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00958	0.0212	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00926	0.0177	CbGpPWpGaD
Tolazamide—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00915	0.0203	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00888	0.017	CbGpPWpGaD
Tolazamide—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00868	0.0192	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00859	0.019	CcSEcCtD
Tolazamide—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00846	0.0187	CcSEcCtD
Tolazamide—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00829	0.0184	CcSEcCtD
Tolazamide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0082	0.0181	CcSEcCtD
Tolazamide—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00792	0.0175	CcSEcCtD
Tolazamide—Urticaria—Spironolactone—dilated cardiomyopathy	0.0079	0.0175	CcSEcCtD
Tolazamide—Pruritus—Spironolactone—dilated cardiomyopathy	0.00704	0.0156	CcSEcCtD
Tolazamide—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00678	0.015	CcSEcCtD
Tolazamide—Erythema—Furosemide—dilated cardiomyopathy	0.00663	0.0147	CcSEcCtD
Tolazamide—Dizziness—Spironolactone—dilated cardiomyopathy	0.00658	0.0146	CcSEcCtD
Tolazamide—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00652	0.0144	CcSEcCtD
Tolazamide—Rash—Spironolactone—dilated cardiomyopathy	0.00627	0.0139	CcSEcCtD
Tolazamide—Headache—Spironolactone—dilated cardiomyopathy	0.00623	0.0138	CcSEcCtD
Tolazamide—Vertigo—Furosemide—dilated cardiomyopathy	0.00596	0.0132	CcSEcCtD
Tolazamide—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00594	0.0131	CcSEcCtD
Tolazamide—Leukopenia—Furosemide—dilated cardiomyopathy	0.00593	0.0131	CcSEcCtD
Tolazamide—Nausea—Spironolactone—dilated cardiomyopathy	0.00591	0.0131	CcSEcCtD
Tolazamide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.0053	0.0117	CcSEcCtD
Tolazamide—KCNJ11—Type II diabetes mellitus—TNF—dilated cardiomyopathy	0.00499	0.00955	CbGpPWpGaD
Tolazamide—Erythema—Lisinopril—dilated cardiomyopathy	0.00497	0.011	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—ABCC9—dilated cardiomyopathy	0.00473	0.00906	CbGpPWpGaD
Tolazamide—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00467	0.0103	CcSEcCtD
Tolazamide—Fatigue—Furosemide—dilated cardiomyopathy	0.00466	0.0103	CcSEcCtD
Tolazamide—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00462	0.0102	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—ABCC9—dilated cardiomyopathy	0.00459	0.00879	CbGpPWpGaD
Tolazamide—ABCC8—Neuronal System—ACTN2—dilated cardiomyopathy	0.00454	0.00869	CbGpPWpGaD
Tolazamide—Malaise—Lisinopril—dilated cardiomyopathy	0.00449	0.00993	CcSEcCtD
Tolazamide—Vertigo—Lisinopril—dilated cardiomyopathy	0.00447	0.00989	CcSEcCtD
Tolazamide—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00446	0.00987	CcSEcCtD
Tolazamide—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00445	0.00986	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—ACTN2—dilated cardiomyopathy	0.0044	0.00842	CbGpPWpGaD
Tolazamide—Urticaria—Furosemide—dilated cardiomyopathy	0.0043	0.00952	CcSEcCtD
Tolazamide—Discomfort—Lisinopril—dilated cardiomyopathy	0.00418	0.00926	CcSEcCtD
Tolazamide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00397	0.0088	CcSEcCtD
Tolazamide—Asthenia—Furosemide—dilated cardiomyopathy	0.00388	0.00859	CcSEcCtD
Tolazamide—Pruritus—Furosemide—dilated cardiomyopathy	0.00383	0.00847	CcSEcCtD
Tolazamide—Dizziness—Furosemide—dilated cardiomyopathy	0.00358	0.00792	CcSEcCtD
Tolazamide—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00357	0.00791	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.0035	0.00776	CcSEcCtD
Tolazamide—Fatigue—Lisinopril—dilated cardiomyopathy	0.0035	0.00775	CcSEcCtD
Tolazamide—Rash—Furosemide—dilated cardiomyopathy	0.00341	0.00755	CcSEcCtD
Tolazamide—Headache—Furosemide—dilated cardiomyopathy	0.00339	0.0075	CcSEcCtD
Tolazamide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00335	0.00741	CcSEcCtD
Tolazamide—Urticaria—Lisinopril—dilated cardiomyopathy	0.00322	0.00714	CcSEcCtD
Tolazamide—Nausea—Furosemide—dilated cardiomyopathy	0.00321	0.00711	CcSEcCtD
Tolazamide—Asthenia—Lisinopril—dilated cardiomyopathy	0.00291	0.00645	CcSEcCtD
Tolazamide—Pruritus—Lisinopril—dilated cardiomyopathy	0.00287	0.00636	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00281	0.00539	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00274	0.00524	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00274	0.00524	CbGpPWpGaD
Tolazamide—Dizziness—Lisinopril—dilated cardiomyopathy	0.00268	0.00594	CcSEcCtD
Tolazamide—Rash—Lisinopril—dilated cardiomyopathy	0.00256	0.00567	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00254	0.00487	CbGpPWpGaD
Tolazamide—Headache—Lisinopril—dilated cardiomyopathy	0.00254	0.00563	CcSEcCtD
Tolazamide—Nausea—Lisinopril—dilated cardiomyopathy	0.00241	0.00534	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—RAF1—dilated cardiomyopathy	0.00202	0.00387	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ANKRD1—dilated cardiomyopathy	0.00185	0.00354	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ANKRD1—dilated cardiomyopathy	0.00179	0.00343	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—TAZ—dilated cardiomyopathy	0.00174	0.00333	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—TAZ—dilated cardiomyopathy	0.00169	0.00323	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SDHA—dilated cardiomyopathy	0.00157	0.00301	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SDHA—dilated cardiomyopathy	0.00152	0.00292	CbGpPWpGaD
Tolazamide—ABCC8—Neuronal System—RAF1—dilated cardiomyopathy	0.00103	0.00198	CbGpPWpGaD
Tolazamide—KCNJ11—Neuronal System—RAF1—dilated cardiomyopathy	0.001	0.00192	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000555	0.00106	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GPX1—dilated cardiomyopathy	0.000427	0.000818	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CD36—dilated cardiomyopathy	0.000416	0.000797	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GPX1—dilated cardiomyopathy	0.000414	0.000793	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CD36—dilated cardiomyopathy	0.000403	0.000772	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—AGT—dilated cardiomyopathy	0.000375	0.000717	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—AGT—dilated cardiomyopathy	0.000363	0.000696	CbGpPWpGaD
